Bilhi Genetics
Bilhi Genetics is a privately held French biotechnology company headquartered in Marseille, founded in 2011, positioned at the intersection of biotechnology and digital technologies. Specific scientific focus, product portfolio, and commercial activities are not disclosed in the available data.
- Company typePrivate
- Founded2011
- HeadquartersMarseille, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Bilhi Genetics does
Bilhi Genetics is a privately held French biotechnology company founded in 2011 and headquartered in Marseille, France. The firm positions itself at the intersection of biotechnology and digital technologies, though the available data does not specify its scientific focus areas, therapeutic or diagnostic pipeline, product portfolio, or service offerings. The company maintains a headcount in the 11–50 range and operates as a for-profit private entity with no public ticker disclosed. No business model, pricing structure, customer segmentation, or revenue mechanics are documented in the input set.
The company's public-facing web presence is currently limited to a default LiteSpeed Web Server directory index page that exposes only a cgi-bin folder, with no substantive product, technology, or corporate content. No products, services, intellectual property filings, partnerships, certifications, customer relationships, pricing structures, funding rounds beyond the 2011 incubator relationship, or revenue figures are disclosed. The only documented external relationship is an incubator engagement with Incubateur Impulse dated July 7, 2011, with $0 disclosed capital — consistent with non-cash incubator support rather than a priced financing round.
Pierre Dessein is identified as co-founder and CEO, providing the single named executive in the available record. There is no evidence of subsequent funding rounds, headcount growth trends, M&A activity, product launches, regulatory filings, geographic expansion, or commercial traction signals. The combination of a 13+ year operating history, persistently small headcount band, and a default web server presence materially constrains any assessment of operational depth or commercial readiness, and any analyst inference beyond the basic firmographic profile is unsupported by the input.
Bilhi Genetics firmographics
Firmographics- Name
- Bilhi Genetics
- Website
- https://bilhigenetics.com
- Company type
- Private
- Founded year
- 2011
- Headcount range
- 11–50 employees
- Short description
- Bilhi Genetics is a privately held French biotechnology company headquartered in Marseille, founded in 2011, positioned at the intersection of biotechnology and digital technologies. Specific scientific focus, product portfolio, and commercial activities are not disclosed in the available data.
- Ownership category
- akta.pro rank
Bilhi Genetics industry classification
Industry- Product category
- Biotechnology Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
Keywords
Where Bilhi Genetics is headquartered
LocationHeadquarters
- HQ city
- Marseille
- HQ country
- France
- HQ region
- Europe
Markets served
Bilhi Genetics business model
Business model- GTM type
- B2B
- Offering type
- Services
Bilhi Genetics product offering
Product offeringCore offering
Bilhi Genetics is described as a biotech company operating at the edge of biotechnology and digital technologies. The company's public website currently does not expose any substantive product, service, or capability content beyond the company description. Specific offerings, deliverables, and revenue activities are not detailed in the available source material.
Differentiator
Problem solved
Functional benefit
Bilhi Genetics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bilhi Genetics partnerships and signals
Strategic signalRecent moves2 records
Bilhi Genetics competitors and assessment
Company assessmentEmerging players
- Eligo Bioscience: Paris-based synthetic biology / engineered phage platform company. Comparable as a France-based emerging player at the intersection of genetics, synthetic biology, and digital design of biological systems.
- DNA Script: French biotech combining enzymatic DNA synthesis with digital/automation workflows. Comparable to Bilhi Genetics as a France-based biotech operating at the intersection of biology and digital technologies, though DNA Script is significantly more capitalised and product-mature.
Direct peers
- Integragen: French genomics services and computational biology company based near Paris. Comparable as a France-based 'biotech at the edge of biology and digital' firm with a services/research model and small headcount.
- Cellectis: Paris-based gene-editing and synthetic biology platform company. Directly comparable as a French biotech working on genetic engineering platforms, with publicly disclosed pipeline assets.
- genOway: Lyon-based transgenic mouse models and custom genetics services company. Comparable as a French 'Genetics'-named biotech with a contract research model targeting academic and pharma customers.
Regional players
- Pharnext: French clinical-stage biotech using computational biology approaches for drug repositioning. Comparable as a France-based biotech applying digital methods to biological problems, though focused on therapeutics rather than genetics platforms.
Broad incumbents
- Novasep: Larger French biopharma services and contract manufacturing organisation. Comparable as a France-based biotech-services incumbent, though materially broader in scope than a genetics-focused niche player like Bilhi.
- Sartorius Stedim Biotech: Major Franco-German bioprocessing and biotech equipment provider. Comparable as a broader European incumbent serving the biotech value chain, useful as a benchmark for what scaled French biotech operations look like.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
Bilhi Genetics social profiles
Digital presenceBilhi Genetics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bilhi Genetics leadership team
Management profileNumber of profiles
Profiles1 record
Bilhi Genetics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bilhi Genetics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bilhi Genetics
What does Bilhi Genetics do?
Bilhi Genetics is described as a biotech company operating at the edge of biotechnology and digital technologies. The company's public website currently does not expose any substantive product, service, or capability content beyond the company description. Specific offerings, deliverables, and revenue activities are not detailed in the available source material.
When was Bilhi Genetics founded?
Bilhi Genetics was founded in 2011. It employs 11 to 50 people.
Where is Bilhi Genetics based?
Bilhi Genetics is headquartered in Marseille, France, in the Europe region.
Who are Bilhi Genetics's main competitors?
Emerging players on record are Eligo Bioscience and DNA Script. Direct peers are Integragen, Cellectis and genOway. Pharnext is listed as a regional player. Broad incumbents are Novasep and Sartorius Stedim Biotech.
Does Bilhi Genetics have an API?
No public API is recorded for Bilhi Genetics.
What industry is Bilhi Genetics in?
Bilhi Genetics's product category is Biotechnology Services. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 541714 and its SIC code is 8731.